G

GemVax & KAEL Co Ltd
KOSDAQ:082270

Watchlist Manager
GemVax & KAEL Co Ltd
KOSDAQ:082270
Watchlist
Price: 33 700 KRW 6.31% Market Closed
Market Cap: 1.3T KRW

GemVax & KAEL Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

GemVax & KAEL Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
G
GemVax & KAEL Co Ltd
KOSDAQ:082270
Operating Income
-â‚©39B
CAGR 3-Years
-151%
CAGR 5-Years
-79%
CAGR 10-Years
-18%
Hanmi Semiconductor Co Ltd
KRX:042700
Operating Income
â‚©255.4B
CAGR 3-Years
28%
CAGR 5-Years
79%
CAGR 10-Years
18%
E
EO Technics Co Ltd
KOSDAQ:039030
Operating Income
â‚©31.5B
CAGR 3-Years
-26%
CAGR 5-Years
35%
CAGR 10-Years
-6%
W
Wonik IPS Co Ltd
KOSDAQ:240810
Operating Income
â‚©10.6B
CAGR 3-Years
-60%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
H
HPSP Co Ltd
KOSDAQ:403870
Operating Income
â‚©93.9B
CAGR 3-Years
28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jusung Engineering Co Ltd
KOSDAQ:036930
Operating Income
â‚©97.2B
CAGR 3-Years
-2%
CAGR 5-Years
27%
CAGR 10-Years
26%

GemVax & KAEL Co Ltd
Glance View

Market Cap
1.3T KRW
Industry
Semiconductors

GemVax & KAEL Co., Ltd. engages in the production of chemical filters and gas scrubbers for semiconductors. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2005-06-24. The firm and its subsidiaries are engaged in the three categories of businesses: pollution control business, which manufactures chemical air (CA) filters, gas scrubbers, resins, coating resins and other environmental equipments and systems; anticancer and anti-inflammation business, which engages in development of cancer vaccines for infectious diseases, such as acquired immune deficiency syndrome (AIDS) and anti-inflammations, and IT business which mainly produces liquid crystal display (LCD) modules. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
3 572.03 KRW
Overvaluation 89%
Intrinsic Value
Price
G

See Also

What is GemVax & KAEL Co Ltd's Operating Income?
Operating Income
-39B KRW

Based on the financial report for Sep 30, 2024, GemVax & KAEL Co Ltd's Operating Income amounts to -39B KRW.

What is GemVax & KAEL Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
-18%

Over the last year, the Operating Income growth was -989%. The average annual Operating Income growth rates for GemVax & KAEL Co Ltd have been -151% over the past three years , -79% over the past five years , and -18% over the past ten years .

Back to Top